Our study, the first study to simultaneously investigate the value of PKG in identifying motor fluctuations and dyskinesia in the Chinese PD population, aims to fill the data gap in this area, and hopefully to further incorporate wearable biosensing devices into clinical practice. The gene discussed is PRKG1; the disease is drug-induced dyskinesia.